Susan J. Ramus
384 Victoria Street
Sydney, NSW 2010, Australia
Sydney, NSW 2010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 246 publications
Aggressive pituitary neuroendocrine tumours display a distinct immune microenvironment.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 20, 2026
Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 28, 2026
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: Research square
Published: November 19, 2025
Evaluating patient perspectives about the acceptability of a novel prognostic gene expression signature for high grade serous ovarian cancer: The OTTA-SPOT study.
Journal: Gynecologic oncology
Published: October 09, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: medRxiv : the preprint server for health sciences
Published: October 03, 2025
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Journal: Nature communications
Published: September 22, 2025
Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.
Journal: Nature communications
Published: September 09, 2025
Aggressive pituitary tumours and pituitary carcinomas: molecular insights guiding management and the role of precision oncology.
Journal: Molecular and cellular endocrinology
Published: March 18, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis.
Journal: Gynecologic oncology
Published: March 05, 2025
Cellular origins of mucinous ovarian carcinoma.
Journal: The Journal of pathology
Published: November 04, 2024
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.
Journal: European journal of human genetics : EJHG
Published: October 04, 2024
IdentifiHR predicts homologous recombination deficiency in high-grade serous ovarian carcinoma using gene expression.
Journal: Communications medicine
Published: September 19, 2024
Last Updated: 09/26/2026